Beijing, China – A recent correction to a BMJ Medicine publication details author affiliations for a landmark study identifying data-driven subtypes of polycystic ovary syndrome (PCOS) and linking them to clinical outcomes. The correction, published [Date of Publication – not provided in source], clarifies the institutional affiliations of the extensive collaborative research team.
The original study,”Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes,” identified four distinct PCOS subtypes – ovulatory,insulin-resistant,inflammatory,and classic – using machine learning analysis of data from over 2,000 Chinese women with PCOS. Researchers demonstrated these subtypes exhibit differing clinical and biochemical characteristics, and varying risks of adverse reproductive outcomes.
The author correction specifically details the affiliations of 33 researchers across 16 institutions:
* Peking University Third hospital, Beijing, China: Yue Zhao
* Reproductive Medicine Research Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China: Xiaoyan Liang & Jingjie Li
* State Key Laboratory of Reproductive Medicine, Clinical Center of reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing, China: Jiayin Liu & Xiang Ma
* Ministry of Education Key Laboratory of Metabolism and molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China: Xiaoying Li & Mingfeng Xia
* Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China: Zhuowei Gu
* Reproductive Medicine center, Xiangya Hospital of Central South University, Changsha, China: Yanping Li
* Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China: Shixuan Wang & Yan Li
* Key Laboratory of Reproductive Genetics, Ministry of Education, Department of Reproductive Endocrinology, Women’s hospital, Zhejiang University School of Medicine, Hangzhou, China: Yuli Qian
* Institute of Genetics, International School of Medicine, Zhejiang University, hangzhou, China: Jun Ma & Feng He
* Department of Reproductive Medicine, The Second Hospital, Cheeloo College of medicine, Shandong University, Jinan, China: Shanshan Gao & Yue Liu
* Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, jinan, china: Yonghui Jiang
* Department of Obstetrics and Gynecology, Shandong Key Laboratory of Reproductive Medicine, shandong Provincial Hospital, Shandong First Medical University, Jinan, China: Shuai Zhao & Hui Zhao.
PCOS affects an estimated 8-13% of women of reproductive age worldwide, representing a significant public health concern. Traditionally diagnosed based on the Rotterdam criteria, this research suggests a more nuanced, subtype-based approach may improve risk stratification and personalized treatment strategies for individuals with PCOS. the identification of these subtypes offers potential for targeted therapies and improved reproductive outcomes for women living with the condition.
